MEDICINE OVERVIEW OF Glimzab MV1 Tablet (10 Tab)

THERAPEUTIC CLASS OF Glimzab MV1 Tablet (10 Tab)

WHY Glimzab MV1 Tablet (10 Tab) IS PRESCRIBED

Substitutes for - Glimzab MV1 Tablet (10 Tab)

HOW IT WORKS

HOW TO TAKE

WHEN TO TAKE

Glimzab MV1 Tablet (10 Tab) Warnings

Precautions of Glimzab MV1 Tablet (10 Tab)

Contraindications of Glimzab MV1 Tablet (10 Tab)

Side Effects of Glimzab MV1 Tablet (10 Tab)

Alcohol Interaction

Food to Avoid

Pregnancy/Lactation Protocol

Storage of Glimzab MV1 Tablet (10 Tab)

Glimzab MV1 Tablet (10 Tab)

Manufactured By: Neucure Lifescience Pvt Ltd
Composition/Salt

Glimepiride 1mg + Metformin 500mg + Voglibose 0.3mg

About Glimzab MV1 Tablet:

Glimzab MV1 Tablet is a combination of three antidiabetic medications, used to treat type 2 diabetes mellitus.

Each uncoated bilayered Glimzab MV1 Tablet contains Metformin Hydrochloride 500 mg (As extended-release), Voglibose 0.3 mg and Glimepiride 1 mg.

Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with type 2 diabetes mellitus.

Glimepiride, an antidiabetic sulphonylurea, reduces blood glucose by stimulating the insulin release from pancreatic ß-cells and decreases glucose output from the liver. It also increases insulin sensitivity at peripheral target sites.

Hence, the combination of Glimepiride, Metformin, and Voglibose complements each other and provides better glycemic control in the management of type 2 diabetes and probably in the prevention of its associated macrovascular and microvascular complications.

Use of Glimzab MV1 Tablet:

Glimzab MV1 Tablet is prescribed for the treatment of patients with type 2 diabetes mellitus. It helps control high blood glucose levels.

Usage Direction of Glimzab MV1 Tablet:

  • Glimzab MV1 Tablet is intended for oral use only, in a dose and direction as prescribed by the physician.
  • Glimzab MV1 Tablet should be swallowed whole.
  • Do not crush or chew the tablet.
  • Do not skip or stop the medicine without the physician’s advice.
  • Do not exceed the stated recommended daily dosage.

Precaution & Related information of Glimzab MV1 Tablet:

  • Caution: It is dangerous to take this preparation except under medical supervision.
  • If hypersensitive or allergic to Glimzab MV1 Tablet, inform the physician immediately.
  • If found any other complications, inform the physician immediately.
  • The physician should be well informed when concomitant consumption of this tablet with any other medicines or supplements.
  • Consult with the physician during pregnancy & lactation.
  • Keep out of reach of children.

Storage condition of Glimzab MV1 Tablet:

  • Store protected from light & moisture, at a temperature not exceeding 30°C.

Loading

Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics and information, contained on or available through this website is for general information purposes only. SastaSundar.com makes no representation and assumes no responsibility for the accuracy of information contained on or available through this website and such information is subject to change without notice. You are encouraged to confirm any information obtained from or through this web site with other sources and review all information regarding any medical condition or treatment with your physician. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH ANY WEBSITE.

SastaSundar.com does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, procedures, treatments, opinions or other information that may be contained on or available through this website.